 | • レポートコード：GIR-107A14304 • 出版社/出版日：GlobalInfoResearch / 2021年7月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、114ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医薬品 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料では、インターロイキン1（IL1）のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。インターロイキン1（IL1）の種類別市場規模（APX-002、カナキヌマブ、ディアセレインCR、IR-1000、その他）、用途別市場規模（食道がん、卵管がん、膀胱がん、ベヒサー病、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・インターロイキン1（IL1）の市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：Optimum Therapeutics LLC、Orphit SAS、Peptinov SAS、AbbVie Inc、Swedish Orphan Biovitrum AB、TWi Biotechnology Inc、XBiotech Inc、Cell Medica Ltd、Exicure Inc、Immune Response BioPharma Inc、Novartis AG、Omnitura Therapeutics Inc、Opsona Therapeutics Ltd、Anacor Pharmaceuticals Inc、Apexigen Inc、R Pharm、Regeneron Pharmaceuticals Inc ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：APX-002、カナキヌマブ、ディアセレインCR、IR-1000、その他 ・用途別分析2016年-2026年：食道がん、卵管がん、膀胱がん、ベヒサー病、その他 ・インターロイキン1（IL1）の北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・インターロイキン1（IL1）のヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・インターロイキン1（IL1）のアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・インターロイキン1（IL1）の南米市場規模2016年-2026年：ブラジル、アルゼンチン ・インターロイキン1（IL1）の中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Interleukin 1 (IL1) market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Interleukin 1 (IL1) size is estimated to be xx million in 2021 from USD xx million in 2020, with a change of XX% between 2020 and 2021. The global Interleukin 1 (IL1) market size is expected to grow at a CAGR of xx% for the next five years.
Market segmentation
Interleukin 1 (IL1) market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
APX-002
Canakinumab
Diacerein CR
IR-1000
Others
Market segment by Application can be divided into
Esophageal Cancer
Fallopian Tube Cancer
Bladder Cancer
Bechcer Disease
Others
The key market players for global Interleukin 1 (IL1) market are listed below:
Optimum Therapeutics LLC
Orphit SAS
Peptinov SAS
AbbVie Inc
Swedish Orphan Biovitrum AB
TWi Biotechnology Inc
XBiotech Inc
Cell Medica Ltd
Exicure Inc
Immune Response BioPharma Inc
Novartis AG
Omnitura Therapeutics Inc
Opsona Therapeutics Ltd
Anacor Pharmaceuticals Inc
Apexigen Inc
R Pharm
Regeneron Pharmaceuticals Inc
Market segment by Region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 14 chapters:
Chapter 1, to describe Interleukin 1 (IL1) product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Interleukin 1 (IL1), with price, sales, revenue and global market share of Interleukin 1 (IL1) from 2019 to 2021.
Chapter 3, the Interleukin 1 (IL1) competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Interleukin 1 (IL1) breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2016 to 2026.
Chapter 5 and 6, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2016 to 2026.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2016 to 2021.and Interleukin 1 (IL1) market forecast, by regions, type and application, with sales and revenue, from 2021 to 2026.
Chapter 12, 13 and 14, to describe Interleukin 1 (IL1) sales channel, distributors, customers, research findings and conclusion, appendix and data source.
1 Market Overview
1.1 Interleukin 1 (IL1) Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Interleukin 1 (IL1) Revenue by Type: 2019 Versus 2021 Versus 2026
1.2.2 APX-002
1.2.3 Canakinumab
1.2.4 Diacerein CR
1.2.5 IR-1000
1.2.6 Others
1.3 Market Analysis by Application
1.3.1 Overview: Global Interleukin 1 (IL1) Revenue by Application: 2019 Versus 2021 Versus 2026
1.3.2 Esophageal Cancer
1.3.3 Fallopian Tube Cancer
1.3.4 Bladder Cancer
1.3.5 Bechcer Disease
1.3.6 Others
1.4 Global Interleukin 1 (IL1) Market Size & Forecast
1.4.1 Global Interleukin 1 (IL1) Sales in Value (2016-2026))
1.4.2 Global Interleukin 1 (IL1) Sales in Volume (2016-2026)
1.4.3 Global Interleukin 1 (IL1) Price by Type (2016-2026) & (USD/Pcs)
1.5 Global Interleukin 1 (IL1) Production Capacity Analysis
1.5.1 Global Interleukin 1 (IL1) Total Production Capacity (2016-2026)
1.5.2 Global Interleukin 1 (IL1) Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Interleukin 1 (IL1) Market Drivers
1.6.2 Interleukin 1 (IL1) Market Restraints
1.6.3 Interleukin 1 (IL1) Trends Analysis
2 Manufacturers Profiles
2.1 Optimum Therapeutics LLC
2.1.1 Optimum Therapeutics LLC Details
2.1.2 Optimum Therapeutics LLC Major Business
2.1.3 Optimum Therapeutics LLC Interleukin 1 (IL1) Product and Services
2.1.4 Optimum Therapeutics LLC Interleukin 1 (IL1) Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.2 Orphit SAS
2.2.1 Orphit SAS Details
2.2.2 Orphit SAS Major Business
2.2.3 Orphit SAS Interleukin 1 (IL1) Product and Services
2.2.4 Orphit SAS Interleukin 1 (IL1) Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.3 Peptinov SAS
2.3.1 Peptinov SAS Details
2.3.2 Peptinov SAS Major Business
2.3.3 Peptinov SAS Interleukin 1 (IL1) Product and Services
2.3.4 Peptinov SAS Interleukin 1 (IL1) Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.4 AbbVie Inc
2.4.1 AbbVie Inc Details
2.4.2 AbbVie Inc Major Business
2.4.3 AbbVie Inc Interleukin 1 (IL1) Product and Services
2.4.4 AbbVie Inc Interleukin 1 (IL1) Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.5 Swedish Orphan Biovitrum AB
2.5.1 Swedish Orphan Biovitrum AB Details
2.5.2 Swedish Orphan Biovitrum AB Major Business
2.5.3 Swedish Orphan Biovitrum AB Interleukin 1 (IL1) Product and Services
2.5.4 Swedish Orphan Biovitrum AB Interleukin 1 (IL1) Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.6 TWi Biotechnology Inc
2.6.1 TWi Biotechnology Inc Details
2.6.2 TWi Biotechnology Inc Major Business
2.6.3 TWi Biotechnology Inc Interleukin 1 (IL1) Product and Services
2.6.4 TWi Biotechnology Inc Interleukin 1 (IL1) Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.7 XBiotech Inc
2.7.1 XBiotech Inc Details
2.7.2 XBiotech Inc Major Business
2.7.3 XBiotech Inc Interleukin 1 (IL1) Product and Services
2.7.4 XBiotech Inc Interleukin 1 (IL1) Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.8 Cell Medica Ltd
2.8.1 Cell Medica Ltd Details
2.8.2 Cell Medica Ltd Major Business
2.8.3 Cell Medica Ltd Interleukin 1 (IL1) Product and Services
2.8.4 Cell Medica Ltd Interleukin 1 (IL1) Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.9 Exicure Inc
2.9.1 Exicure Inc Details
2.9.2 Exicure Inc Major Business
2.9.3 Exicure Inc Interleukin 1 (IL1) Product and Services
2.9.4 Exicure Inc Interleukin 1 (IL1) Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.10 Immune Response BioPharma Inc
2.10.1 Immune Response BioPharma Inc Details
2.10.2 Immune Response BioPharma Inc Major Business
2.10.3 Immune Response BioPharma Inc Interleukin 1 (IL1) Product and Services
2.10.4 Immune Response BioPharma Inc Interleukin 1 (IL1) Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.11 Novartis AG
2.11.1 Novartis AG Details
2.11.2 Novartis AG Major Business
2.11.3 Novartis AG Interleukin 1 (IL1) Product and Services
2.11.4 Novartis AG Interleukin 1 (IL1) Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.12 Omnitura Therapeutics Inc
2.12.1 Omnitura Therapeutics Inc Details
2.12.2 Omnitura Therapeutics Inc Major Business
2.12.3 Omnitura Therapeutics Inc Interleukin 1 (IL1) Product and Services
2.12.4 Omnitura Therapeutics Inc Interleukin 1 (IL1) Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.13 Opsona Therapeutics Ltd
2.13.1 Opsona Therapeutics Ltd Details
2.13.2 Opsona Therapeutics Ltd Major Business
2.13.3 Opsona Therapeutics Ltd Interleukin 1 (IL1) Product and Services
2.13.4 Opsona Therapeutics Ltd Interleukin 1 (IL1) Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.14 Anacor Pharmaceuticals Inc
2.14.1 Anacor Pharmaceuticals Inc Details
2.14.2 Anacor Pharmaceuticals Inc Major Business
2.14.3 Anacor Pharmaceuticals Inc Interleukin 1 (IL1) Product and Services
2.14.4 Anacor Pharmaceuticals Inc Interleukin 1 (IL1) Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.15 Apexigen Inc
2.15.1 Apexigen Inc Details
2.15.2 Apexigen Inc Major Business
2.15.3 Apexigen Inc Interleukin 1 (IL1) Product and Services
2.15.4 Apexigen Inc Interleukin 1 (IL1) Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.16 R Pharm
2.16.1 R Pharm Details
2.16.2 R Pharm Major Business
2.16.3 R Pharm Interleukin 1 (IL1) Product and Services
2.16.4 R Pharm Interleukin 1 (IL1) Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.17 Regeneron Pharmaceuticals Inc
2.17.1 Regeneron Pharmaceuticals Inc Details
2.17.2 Regeneron Pharmaceuticals Inc Major Business
2.17.3 Regeneron Pharmaceuticals Inc Interleukin 1 (IL1) Product and Services
2.17.4 Regeneron Pharmaceuticals Inc Interleukin 1 (IL1) Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
3 Interleukin 1 (IL1) Sales by Manufacturer
3.1 Global Interleukin 1 (IL1) Sales in Volume by Manufacturer (2019-2021e)
3.2 Global Interleukin 1 (IL1) Revenue by Manufacturer (2019-2021e)
3.3 Key Manufacturer Market Position in Interleukin 1 (IL1)
3.4 Market Concentration Rate
3.4.1 Top 3 Interleukin 1 (IL1) Manufacturer Market Share
3.4.2 Top 6 Interleukin 1 (IL1) Manufacturer Market Share
3.5 Global Interleukin 1 (IL1) Production Capacity by Company
3.6 Manufacturer by Geography: Head Office and Interleukin 1 (IL1) Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Interleukin 1 (IL1) Market Size by Region
4.1.1 Global Interleukin 1 (IL1) Sales in Volume by Region (2016-2026)
4.1.2 Global Interleukin 1 (IL1) Revenue by Region (2016-2026)
4.2 North America Interleukin 1 (IL1) Revenue (2016-2026)
4.3 Europe Interleukin 1 (IL1) Revenue (2016-2026)
4.4 Asia-Pacific Interleukin 1 (IL1) Revenue (2016-2026)
4.5 South America Interleukin 1 (IL1) Revenue (2016-2026)
4.6 Middle East and Africa Interleukin 1 (IL1) Revenue (2016-2026)
5 Market Segment by Type
5.1 Global Interleukin 1 (IL1) Sales in Volume by Type (2016-2026)
5.2 Global Interleukin 1 (IL1) Revenue by Type (2016-2026)
5.3 Global Interleukin 1 (IL1) Price by Type (2016-2026)
6 Market Segment by Application
6.1 Global Interleukin 1 (IL1) Sales in Volume by Application (2016-2026)
6.2 Global Interleukin 1 (IL1) Revenue by Application (2016-2026)
6.3 Global Interleukin 1 (IL1) Price by Application (2016-2026)
7 North America by Country, by Type, and by Application
7.1 North America Interleukin 1 (IL1) Sales by Type (2016-2026)
7.2 North America Interleukin 1 (IL1) Sales by Application (2016-2026)
7.3 North America Interleukin 1 (IL1) Market Size by Country
7.3.1 North America Interleukin 1 (IL1) Sales in Volume by Country (2016-2026)
7.3.2 North America Interleukin 1 (IL1) Revenue by Country (2016-2026)
7.3.3 United States Market Size and Forecast (2016-2026)
7.3.4 Canada Market Size and Forecast (2016-2026)
7.3.5 Mexico Market Size and Forecast (2016-2026)
8 Europe by Country, by Type, and by Application
8.1 Europe Interleukin 1 (IL1) Sales by Type (2016-2026)
8.2 Europe Interleukin 1 (IL1) Sales by Application (2016-2026)
8.3 Europe Interleukin 1 (IL1) Market Size by Country
8.3.1 Europe Interleukin 1 (IL1) Sales in Volume by Country (2016-2026)
8.3.2 Europe Interleukin 1 (IL1) Revenue by Country (2016-2026)
8.3.3 Germany Market Size and Forecast (2016-2026)
8.3.4 France Market Size and Forecast (2016-2026)
8.3.5 United Kingdom Market Size and Forecast (2016-2026)
8.3.6 Russia Market Size and Forecast (2016-2026)
8.3.7 Italy Market Size and Forecast (2016-2026)
9 Asia-Pacific by Country, by Type, and by Application
9.1 Asia-Pacific Interleukin 1 (IL1) Sales by Type (2016-2026)
9.2 Asia-Pacific Interleukin 1 (IL1) Sales by Application (2016-2026)
9.3 Asia-Pacific Interleukin 1 (IL1) Market Size by Region
9.3.1 Asia-Pacific Interleukin 1 (IL1) Sales in Volume by Region (2016-2026)
9.3.2 Asia-Pacific Interleukin 1 (IL1) Revenue by Region (2016-2026)
9.3.3 China Market Size and Forecast (2016-2026)
9.3.4 Japan Market Size and Forecast (2016-2026)
9.3.5 Korea Market Size and Forecast (2016-2026)
9.3.6 India Market Size and Forecast (2016-2026)
9.3.7 Southeast Asia Market Size and Forecast (2016-2026)
9.3.8 Australia Market Size and Forecast (2016-2026)
10 South America by Country, by Type, and by Application
10.1 South America Interleukin 1 (IL1) Sales by Type (2016-2026)
10.2 South America Interleukin 1 (IL1) Sales by Application (2016-2026)
10.3 South America Interleukin 1 (IL1) Market Size by Country
10.3.1 South America Interleukin 1 (IL1) Sales in Volume by Country (2016-2026)
10.3.2 South America Interleukin 1 (IL1) Revenue by Country (2016-2026)
10.3.3 Brazil Market Size and Forecast (2016-2026)
10.3.4 Argentina Market Size and Forecast (2016-2026)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Interleukin 1 (IL1) Sales by Type (2016-2026)
11.2 Middle East & Africa Interleukin 1 (IL1) Sales by Application (2016-2026)
11.3 Middle East & Africa Interleukin 1 (IL1) Market Size by Country
11.3.1 Middle East & Africa Interleukin 1 (IL1) Sales in Volume by Country (2016-2026)
11.3.2 Middle East & Africa Interleukin 1 (IL1) Revenue by Country (2016-2026)
11.3.3 Turkey Market Size and Forecast (2016-2026)
11.3.4 Egypt Market Size and Forecast (2016-2026)
11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)
11.3.6 South Africa Market Size and Forecast (2016-2026)
12 Sales Channel, Distributors, Traders and Dealers
12.1 Sales Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.2 Interleukin 1 (IL1) Typical Distributors
12.3 Interleukin 1 (IL1) Typical Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
Table 1. Global Interleukin 1 (IL1) Revenue by Type, (USD Million), 2021-2026
Table 2. Global Interleukin 1 (IL1) Revenue by Application, (USD Million), 2021-2026
Table 3. Optimum Therapeutics LLC Basic Information, Manufacturing Base and Competitors
Table 4. Optimum Therapeutics LLC Major Business
Table 5. Optimum Therapeutics LLC Interleukin 1 (IL1) Product and Services
Table 6. Optimum Therapeutics LLC Interleukin 1 (IL1) Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 7. Orphit SAS Basic Information, Manufacturing Base and Competitors
Table 8. Orphit SAS Major Business
Table 9. Orphit SAS Interleukin 1 (IL1) Product and Services
Table 10. Orphit SAS Interleukin 1 (IL1) Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 11. Peptinov SAS Basic Information, Manufacturing Base and Competitors
Table 12. Peptinov SAS Major Business
Table 13. Peptinov SAS Interleukin 1 (IL1) Product and Services
Table 14. Peptinov SAS Interleukin 1 (IL1) Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 15. AbbVie Inc Basic Information, Manufacturing Base and Competitors
Table 16. AbbVie Inc Major Business
Table 17. AbbVie Inc Interleukin 1 (IL1) Product and Services
Table 18. AbbVie Inc Interleukin 1 (IL1) Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 19. Swedish Orphan Biovitrum AB Basic Information, Manufacturing Base and Competitors
Table 20. Swedish Orphan Biovitrum AB Major Business
Table 21. Swedish Orphan Biovitrum AB Interleukin 1 (IL1) Product and Services
Table 22. Swedish Orphan Biovitrum AB Interleukin 1 (IL1) Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 23. TWi Biotechnology Inc Basic Information, Manufacturing Base and Competitors
Table 24. TWi Biotechnology Inc Major Business
Table 25. TWi Biotechnology Inc Interleukin 1 (IL1) Product and Services
Table 26. TWi Biotechnology Inc Interleukin 1 (IL1) Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 27. XBiotech Inc Basic Information, Manufacturing Base and Competitors
Table 28. XBiotech Inc Major Business
Table 29. XBiotech Inc Interleukin 1 (IL1) Product and Services
Table 30. XBiotech Inc Interleukin 1 (IL1) Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 31. Cell Medica Ltd Basic Information, Manufacturing Base and Competitors
Table 32. Cell Medica Ltd Major Business
Table 33. Cell Medica Ltd Interleukin 1 (IL1) Product and Services
Table 34. Cell Medica Ltd Interleukin 1 (IL1) Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 35. Exicure Inc Basic Information, Manufacturing Base and Competitors
Table 36. Exicure Inc Major Business
Table 37. Exicure Inc Interleukin 1 (IL1) Product and Services
Table 38. Exicure Inc Interleukin 1 (IL1) Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 39. Immune Response BioPharma Inc Basic Information, Manufacturing Base and Competitors
Table 40. Immune Response BioPharma Inc Major Business
Table 41. Immune Response BioPharma Inc Interleukin 1 (IL1) Product and Services
Table 42. Immune Response BioPharma Inc Interleukin 1 (IL1) Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 43. Novartis AG Basic Information, Manufacturing Base and Competitors
Table 44. Novartis AG Major Business
Table 45. Novartis AG Interleukin 1 (IL1) Product and Services
Table 46. Novartis AG Interleukin 1 (IL1) Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 47. Omnitura Therapeutics Inc Basic Information, Manufacturing Base and Competitors
Table 48. Omnitura Therapeutics Inc Major Business
Table 49. Omnitura Therapeutics Inc Interleukin 1 (IL1) Product and Services
Table 50. Omnitura Therapeutics Inc Interleukin 1 (IL1) Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 51. Opsona Therapeutics Ltd Basic Information, Manufacturing Base and Competitors
Table 52. Opsona Therapeutics Ltd Major Business
Table 53. Opsona Therapeutics Ltd Interleukin 1 (IL1) Product and Services
Table 54. Opsona Therapeutics Ltd Interleukin 1 (IL1) Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 55. Anacor Pharmaceuticals Inc Basic Information, Manufacturing Base and Competitors
Table 56. Anacor Pharmaceuticals Inc Major Business
Table 57. Anacor Pharmaceuticals Inc Interleukin 1 (IL1) Product and Services
Table 58. Anacor Pharmaceuticals Inc Interleukin 1 (IL1) Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 59. Apexigen Inc Basic Information, Manufacturing Base and Competitors
Table 60. Apexigen Inc Major Business
Table 61. Apexigen Inc Interleukin 1 (IL1) Product and Services
Table 62. Apexigen Inc Interleukin 1 (IL1) Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 63. R Pharm Basic Information, Manufacturing Base and Competitors
Table 64. R Pharm Major Business
Table 65. R Pharm Interleukin 1 (IL1) Product and Services
Table 66. R Pharm Interleukin 1 (IL1) Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 67. Regeneron Pharmaceuticals Inc Basic Information, Manufacturing Base and Competitors
Table 68. Regeneron Pharmaceuticals Inc Major Business
Table 69. Regeneron Pharmaceuticals Inc Interleukin 1 (IL1) Product and Services
Table 70. Regeneron Pharmaceuticals Inc Interleukin 1 (IL1) Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 71. Global Interleukin 1 (IL1) Sales by Manufacturer (2019-2021e) & (K Pcs)
Table 72. Global Interleukin 1 (IL1) Revenue by Manufacturer (2019-2021e) & (USD Million)
Table 73. Market Position of Manufacturers in Interleukin 1 (IL1), (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020
Table 74. Global Interleukin 1 (IL1) Production Capacity by Company, (K Pcs): 2020 VS 2021
Table 75. Head Office and Interleukin 1 (IL1) Production Site of Key Manufacturer
Table 76. Interleukin 1 (IL1) New Entrant and Capacity Expansion Plans
Table 77. Interleukin 1 (IL1) Mergers & Acquisitions in the Past Five Years
Table 78. Global Interleukin 1 (IL1) Sales by Region (2016-2021e) & (K Pcs)
Table 79. Global Interleukin 1 (IL1) Sales by Region (2021-2026) & (K Pcs)
Table 80. Global Interleukin 1 (IL1) Revenue by Region (2016-2021e) & (USD Million)
Table 81. Global Interleukin 1 (IL1) Revenue by Region (2021-2026) & (USD Million)
Table 82. Global Interleukin 1 (IL1) Sales by Type (2016-2021e) & (K Pcs)
Table 83. Global Interleukin 1 (IL1) Sales by Type (2021-2026) & (K Pcs)
Table 84. Global Interleukin 1 (IL1) Revenue by Type (2016-2021e) & (USD Million)
Table 85. Global Interleukin 1 (IL1) Revenue by Type (2021-2026) & (USD Million)
Table 86. Global Interleukin 1 (IL1) Price by Type (2016-2021e) & (USD/Pcs)
Table 87. Global Interleukin 1 (IL1) Price by Type (2021-2026) & (USD/Pcs)
Table 88. Global Interleukin 1 (IL1) Sales by Application (2016-2021e) & (K Pcs)
Table 89. Global Interleukin 1 (IL1) Sales by Application (2021-2026) & (K Pcs)
Table 90. Global Interleukin 1 (IL1) Revenue by Application (2016-2021e) & (USD Million)
Table 91. Global Interleukin 1 (IL1) Revenue by Application (2021-2026) & (USD Million)
Table 92. Global Interleukin 1 (IL1) Price by Application (2016-2021e) & (USD/Pcs)
Table 93. Global Interleukin 1 (IL1) Price by Application (2021-2026) & (USD/Pcs)
Table 94. North America Interleukin 1 (IL1) Sales by Country (2016-2021e) & (K Pcs)
Table 95. North America Interleukin 1 (IL1) Sales by Country (2021-2026) & (K Pcs)
Table 96. North America Interleukin 1 (IL1) Revenue by Country (2016-2021e) & (USD Million)
Table 97. North America Interleukin 1 (IL1) Revenue by Country (2021-2026) & (USD Million)
Table 98. North America Interleukin 1 (IL1) Sales by Type (2016-2021e) & (K Pcs)
Table 99. North America Interleukin 1 (IL1) Sales by Type (2021-2026) & (K Pcs)
Table 100. North America Interleukin 1 (IL1) Sales by Application (2016-2021e) & (K Pcs)
Table 101. North America Interleukin 1 (IL1) Sales by Application (2021-2026) & (K Pcs)
Table 102. Europe Interleukin 1 (IL1) Sales by Country (2016-2021e) & (K Pcs)
Table 103. Europe Interleukin 1 (IL1) Sales by Country (2021-2026) & (K Pcs)
Table 104. Europe Interleukin 1 (IL1) Revenue by Country (2016-2021e) & (USD Million)
Table 105. Europe Interleukin 1 (IL1) Revenue by Country (2021-2026) & (USD Million)
Table 106. Europe Interleukin 1 (IL1) Sales by Type (2016-2021e) & (K Pcs)
Table 107. Europe Interleukin 1 (IL1) Sales by Type (2021-2026) & (K Pcs)
Table 108. Europe Interleukin 1 (IL1) Sales by Application (2016-2021e) & (K Pcs)
Table 109. Europe Interleukin 1 (IL1) Sales by Application (2021-2026) & (K Pcs)
Table 110. Asia-Pacific Interleukin 1 (IL1) Sales by Region (2016-2021e) & (K Pcs)
Table 111. Asia-Pacific Interleukin 1 (IL1) Sales by Region (2021-2026) & (K Pcs)
Table 112. Asia-Pacific Interleukin 1 (IL1) Revenue by Region (2016-2021e) & (USD Million)
Table 113. Asia-Pacific Interleukin 1 (IL1) Revenue by Region (2021-2026) & (USD Million)
Table 114. Asia-Pacific Interleukin 1 (IL1) Sales by Type (2016-2021e) & (K Pcs)
Table 115. Asia-Pacific Interleukin 1 (IL1) Sales by Type (2021-2026) & (K Pcs)
Table 116. Asia-Pacific Interleukin 1 (IL1) Sales by Application (2016-2021e) & (K Pcs)
Table 117. Asia-Pacific Interleukin 1 (IL1) Sales by Application (2021-2026) & (K Pcs)
Table 118. South America Interleukin 1 (IL1) Sales by Country (2016-2021e) & (K Pcs)
Table 119. South America Interleukin 1 (IL1) Sales by Country (2021-2026) & (K Pcs)
Table 120. South America Interleukin 1 (IL1) Revenue by Country (2016-2021e) & (USD Million)
Table 121. South America Interleukin 1 (IL1) Revenue by Country (2021-2026) & (USD Million)
Table 122. South America Interleukin 1 (IL1) Sales by Type (2016-2021e) & (K Pcs)
Table 123. South America Interleukin 1 (IL1) Sales by Type (2021-2026) & (K Pcs)
Table 124. South America Interleukin 1 (IL1) Sales by Application (2016-2021e) & (K Pcs)
Table 125. South America Interleukin 1 (IL1) Sales by Application (2021-2026) & (K Pcs)
Table 126. Middle East & Africa Interleukin 1 (IL1) Sales by Country (2016-2021e) & (K Pcs)
Table 127. Middle East & Africa Interleukin 1 (IL1) Sales by Country (2021-2026) & (K Pcs)
Table 128. Middle East & Africa Interleukin 1 (IL1) Revenue by Country (2016-2021e) & (USD Million)
Table 129. Middle East & Africa Interleukin 1 (IL1) Revenue by Country (2021-2026) & (USD Million)
Table 130. Middle East & Africa Interleukin 1 (IL1) Sales by Type (2016-2021e) & (K Pcs)
Table 131. Middle East & Africa Interleukin 1 (IL1) Sales by Type (2021-2026) & (K Pcs)
Table 132. Middle East & Africa Interleukin 1 (IL1) Sales by Application (2016-2021e) & (K Pcs)
Table 133. Middle East & Africa Interleukin 1 (IL1) Sales by Application (2021-2026) & (K Pcs)
Table 134. Direct Channel Pros & Cons
Table 135. Indirect Channel Pros & Cons
Table 136. Interleukin 1 (IL1) Typical Distributors
Table 137. Interleukin 1 (IL1) Typical Customers
List of Figures
Figure 1. Interleukin 1 (IL1) Picture
Figure 2. Global Interleukin 1 (IL1) Sales Market Share by Type in 2020
Figure 3. APX-002
Figure 4. Canakinumab
Figure 5. Diacerein CR
Figure 6. IR-1000
Figure 7. Others
Figure 8. Global Interleukin 1 (IL1) Sales Market Share by Application in 2020
Figure 9. Esophageal Cancer
Figure 10. Fallopian Tube Cancer
Figure 11. Bladder Cancer
Figure 12. Bechcer Disease
Figure 13. Others
Figure 14. Global Interleukin 1 (IL1) Market Size, (USD Million) & (K Pcs): 2020 VS 2021 VS 2026
Figure 15. Global Interleukin 1 (IL1) Market Size and Forecast (2016-2026) & (USD Million)
Figure 16. Global Interleukin 1 (IL1) Sales (2016-2026) & (K Pcs)
Figure 17. Global Interleukin 1 (IL1) Price by Type (2016-2026) & (USD/Pcs)
Figure 18. Global Interleukin 1 (IL1) Production Capacity (2016-2026) & (K Pcs)
Figure 19. Global Interleukin 1 (IL1) Production Capacity by Geographic Region: 2020 VS 2021
Figure 20. Interleukin 1 (IL1) Market Drivers
Figure 21. Interleukin 1 (IL1) Market Restraints
Figure 22. Interleukin 1 (IL1) Market Trends
Figure 23. Global Interleukin 1 (IL1) Sales Market Share by Manufacturer in 2020
Figure 24. Global Interleukin 1 (IL1) Revenue Market Share by Manufacturer in 2020
Figure 25. Interleukin 1 (IL1) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 26. Top 3 Interleukin 1 (IL1) Manufacturer (Revenue) Market Share in 2020
Figure 27. Top 6 Interleukin 1 (IL1) Manufacturer (Revenue) Market Share in 2020
Figure 28. Global Interleukin 1 (IL1) Sales Market Share by Region (2016-2026)
Figure 29. Global Interleukin 1 (IL1) Revenue Market Share by Region (2016-2026)
Figure 30. North America Interleukin 1 (IL1) Revenue (2016-2026) & (USD Million)
Figure 31. Europe Interleukin 1 (IL1) Revenue (2016-2026) & (USD Million)
Figure 32. Asia-Pacific Interleukin 1 (IL1) Revenue (2016-2026) & (USD Million)
Figure 33. South America Interleukin 1 (IL1) Revenue (2016-2026) & (USD Million)
Figure 34. Middle East & Africa Interleukin 1 (IL1) Revenue (2016-2026) & (USD Million)
Figure 35. Global Interleukin 1 (IL1) Sales Market Share by Type (2016-2026)
Figure 36. Global Interleukin 1 (IL1) Revenue Market Share by Type (2016-2026)
Figure 37. Global Interleukin 1 (IL1) Price by Type (2016-2026) & (USD/Pcs)
Figure 38. Global Interleukin 1 (IL1) Sales Market Share by Application (2016-2026)
Figure 39. Global Interleukin 1 (IL1) Revenue Market Share by Application (2016-2026)
Figure 40. Global Interleukin 1 (IL1) Price by Application (2016-2026) & (USD/Pcs)
Figure 41. North America Interleukin 1 (IL1) Sales Market Share by Type (2016-2026)
Figure 42. North America Interleukin 1 (IL1) Sales Market Share by Application (2016-2026)
Figure 43. North America Interleukin 1 (IL1) Sales Market Share by Country (2016-2026)
Figure 44. North America Interleukin 1 (IL1) Revenue Market Share by Country (2016-2026)
Figure 45. United States Interleukin 1 (IL1) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 46. Canada Interleukin 1 (IL1) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 47. Mexico Interleukin 1 (IL1) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 48. Europe Interleukin 1 (IL1) Sales Market Share by Type (2016-2026)
Figure 49. Europe Interleukin 1 (IL1) Sales Market Share by Application (2016-2026)
Figure 50. Europe Interleukin 1 (IL1) Sales Market Share by Country (2016-2026)
Figure 51. Europe Interleukin 1 (IL1) Revenue Market Share by Country (2016-2026)
Figure 52. Germany Interleukin 1 (IL1) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 53. France Interleukin 1 (IL1) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 54. United Kingdom Interleukin 1 (IL1) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 55. Russia Interleukin 1 (IL1) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 56. Italy Interleukin 1 (IL1) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 57. Asia-Pacific Interleukin 1 (IL1) Sales Market Share by Region (2016-2026)
Figure 58. Asia-Pacific Interleukin 1 (IL1) Sales Market Share by Application (2016-2026)
Figure 59. Asia-Pacific Interleukin 1 (IL1) Sales Market Share by Region (2016-2026)
Figure 60. Asia-Pacific Interleukin 1 (IL1) Revenue Market Share by Region (2016-2026)
Figure 61. China Interleukin 1 (IL1) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 62. Japan Interleukin 1 (IL1) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 63. Korea Interleukin 1 (IL1) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 64. India Interleukin 1 (IL1) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 65. Southeast Asia Interleukin 1 (IL1) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 66. Australia Interleukin 1 (IL1) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 67. South America Interleukin 1 (IL1) Sales Market Share by Type (2016-2026)
Figure 68. South America Interleukin 1 (IL1) Sales Market Share by Application (2016-2026)
Figure 69. South America Interleukin 1 (IL1) Sales Market Share by Country (2016-2026)
Figure 70. South America Interleukin 1 (IL1) Revenue Market Share by Country (2016-2026)
Figure 71. Brazil Interleukin 1 (IL1) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 72. Argentina Interleukin 1 (IL1) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 73. Middle East & Africa Interleukin 1 (IL1) Sales Market Share by Type (2016-2026)
Figure 74. Middle East & Africa Interleukin 1 (IL1) Sales Market Share by Application (2016-2026)
Figure 75. Middle East & Africa Interleukin 1 (IL1) Sales Market Share by Country (2016-2026)
Figure 76. Middle East & Africa Interleukin 1 (IL1) Revenue Market Share by Country (2016-2026)
Figure 77. Turkey Interleukin 1 (IL1) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 78. Egypt Interleukin 1 (IL1) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 79. Saudi Arabia Interleukin 1 (IL1) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 80. South Africa Interleukin 1 (IL1) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 81. Sales Channel: Direct Channel vs Indirect Channel
Figure 82. Methodology
Figure 83. Research Process and Data Source
世界のインターロイキン7受容体サブユニットα市場 2021：企業別、地域別、種類・用途別 The Interleukin 7 Receptor Subunit Alpha market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, …- 世界のインターロイキン1受容体関連キナーゼ4市場 2021：企業別、地域別、種類・用途別 The Interleukin 1 Receptor Associated Kinase 4 market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimiza…
- 世界の遺伝子組換え型ヒトインターロイキン市場 2021：企業別、地域別、種類・用途別 The Recombinant Human Interleukin market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade r…
- 世界の組換えヒトインターロイキン2注射市場 2021：企業別、地域別、種類・用途別 The Recombinant Human Interleukin 2 Injection market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimizat…
- 世界の子宮がん治療・診断市場 2021：企業別、地域別、種類・用途別 The Uterine Cancer Therapies and Diagnostic market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimizatio…